Skip to Main Content

Paper Details

A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours.
Cancer Chemother Pharmacol
0
2021
Author NameAffiliation
James R WhittlePeter MacCallum Cancer Centre
James R WhittlePeter MacCallum Cancer Centre
  • 1 - 2

Datasets

Release 1.2